cjc-1295 ipamorelin 5 days on 2 days off protocol no-DAC + Ipamorelin: What It Does (Consumer Q&A) CJC-1295 + Ipamorelin – Growth
Description
GR closes the redox cycle

This blend combines the selective ghrelin receptor agonist Ipamorelin with CJC-1295 (no DAC, Mod GRF 1-29), a Growth Hormone Releasing Hormone (GHRH) analog, studied in experimental models of pituitary function and growth hormone (GH) secretion dynamics
doi: 10.1042/BST20190088 31 XuWWangYHouGWangJWangTQianJet al

Its primary efficacy lies in its ability to recruit specialized cells to the site of damage and modulate the inflammatory cytokine profile